5 Stocks That Will Change the Future

In this article, we will be taking a look at 5 stocks that will change the future. To read our detailed analysis of how the market is transforming this year, you can go directly to see the 10 Stocks That Will Change the Future.

5. GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Number of Hedge Fund Holders: 37

Patrick Wood, an analyst at Morgan Stanley, maintains an Equal Weight rating on shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) as of July 26. The analyst also raised his price target on the stock from $76 to $78.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) was seen in the portfolios of 37 hedge funds at the end of the first quarter. Their total stake value in the company was $955.9 million.

Based in Chicago, Illinois, GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a healthcare equipment company that develops products, services, and complementary digital solutions in the diagnosis, treatment, and monitoring of patients. The company is a leader in the diagnostic equipment space since it offers scanners that are vital for the monitoring and detection of Alzheimer’s disease. Its scanners can accurately check whether medications for this disease are working, which can significantly change the way healthcare for such diseases operates in the future.

This is what Vulcan Value Partners had to say about GE HealthCare Technologies Inc. (NASDAQ:GEHC) in its first-quarter 2023 investor letter:

“We sold GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the quarter. GE HealthCare is a recent spin-off from General Electric Company and provides imaging, ultrasound, patient care solutions and pharmaceutical diagnostics to customers around the world. The company is a leader in a global oligopoly and has a massive installed base. Half of the company’s revenue is recurring, margins are stable to rising, and it generates significant free cash flow. As a recent operating unit inside of GE, we believe the market has been undervaluing this asset. Although the spin price reflected this under-valuation, after the spin-off, its stock price rose to meet our estimate of its intrinsic value, and we sold the position. GE HealthCare remains on our MVP list.”